Partner Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-14,720
Closed -$768K – 76
2019
Q3
$768K Sell
14,720
-2,552
-15% -$136K 1.32% 30
2019
Q2
$866K Buy
17,272
+1,910
+12% +$93K 0.92% 42
2019
Q1
$799K Sell
15,362
-1,261
-8% -$58.1K 0.92% 41
2018
Q4
$812K Sell
16,623
-4,135
-20% -$228K 1.01% 36
2018
Q3
$1.35M Sell
20,758
-1,673
-7% -$98.4K 1.04% 38
2018
Q2
$1.11M Buy
22,431
+9,760
+77% +$473K 0.9% 44
2018
Q1
$618K Sell
12,671
-5,830
-32% -$303K 0.67% 52
2017
Q4
$779K Sell
18,501
-4,236
-19% -$163K 0.9% 43
2017
Q3
$974K Sell
22,737
-4,633
-17% -$148K 0.92% 39
2017
Q2
$359K Sell
27,370
-3,587
-12% -$47.3K 0.48% 59
2017
Q1
$407K Sell
30,957
-1,539
-5% -$19.7K 0.5% 66
2016
Q4
$421K Buy
32,496
+6,998
+27% +$108K 0.56% 60
2016
Q3
$417K Buy
25,498
+9,311
+58% +$168K 0.62% 56
2016
Q2
$201K Buy
16,187
+687
+4% +$8.59K 0.33% 69
2016
Q1
$166K Sell
15,500
-103
-0.7% -$937 0.27% 69
2015
Q4
$229K Buy
+15,603
New +$191K 0.38% 55

Other funds holding MYOK

Partner Investment Management's MYOK Position: Q4 2019 in Review

Partner Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2019, closing a stake of 14,720 shares — an estimated $768K sold.

Partner Investment Management first reported a position in MYOK in Q4 2015 and held it in 16 quarters. The position peaked at $1.35M in Q3 2018. 178 funds tracked by Wall St. Rank hold MYOK as of Q4 2019.

  • Partner Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Partner Investment Management sold 14,720 MyoKardia, Inc. Common Stock shares in Q4 2019, an estimated $768K.
  • Partner Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 16 quarters.
  • Partner Investment Management's MyoKardia, Inc. Common Stock position peaked at $1.35M in Q3 2018.
  • 178 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.